News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,402 Results
Type
Article (54265)
Company Profile (396)
Press Release (642729)
Multimedia
Podcasts (127)
Webinars (19)
Section
Business (187702)
Career Advice (2543)
Deals (33467)
Drug Delivery (130)
Drug Development (81949)
Employer Resources (152)
FDA (16610)
Job Trends (14677)
News (327473)
Policy (32313)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2869)
Academic (1)
Accelerated approval (38)
Adcomms (32)
Allergies (158)
Alliances (48038)
ALS (189)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (357)
Approvals (16847)
Artificial intelligence (597)
Autoimmune disease (177)
Automation (44)
Bankruptcy (355)
Best Places to Work (11519)
BIOSECURE Act (17)
Biosimilars (188)
Biotechnology (290)
Bladder cancer (171)
Brain cancer (66)
Breast cancer (680)
Cancer (5172)
Cardiovascular disease (447)
Career advice (2164)
Career pathing (41)
CAR-T (305)
CDC (54)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (38)
Clinical research (69897)
Collaboration (1876)
Company closure (4)
Compensation (951)
Complete response letters (72)
COVID-19 (2819)
CRISPR (107)
C-suite (939)
Cystic fibrosis (150)
Data (6554)
Decentralized trials (2)
Denatured (38)
Depression (156)
Diabetes (525)
Diagnostics (6687)
Digital health (48)
Diversity (10)
Diversity, equity & inclusion (42)
Drug discovery (281)
Drug pricing (198)
Drug shortages (30)
Duchenne muscular dystrophy (254)
Earnings (73943)
Editorial (62)
Employer branding (20)
Employer resources (143)
Events (107744)
Executive appointments (1052)
FDA (19888)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1556)
Gene editing (227)
Generative AI (53)
Gene therapy (679)
GLP-1 (1081)
Government (4896)
Grass and pollen (7)
Guidances (387)
Healthcare (19377)
HIV (71)
Huntington's disease (52)
IgA nephropathy (89)
Immunology and inflammation (287)
Immuno-oncology (70)
Indications (127)
Infectious disease (3119)
Inflammatory bowel disease (216)
Inflation Reduction Act (16)
Influenza (127)
Intellectual property (264)
Interviews (535)
IPO (15498)
IRA (56)
Job creations (3524)
Job search strategy (1751)
JPM (66)
Kidney cancer (20)
Labor market (68)
Layoffs (580)
Leadership (42)
Legal (7235)
Liver cancer (97)
Longevity (18)
Lung cancer (706)
Lymphoma (387)
Machine learning (47)
Management (53)
Manufacturing (813)
MASH (181)
Medical device (14568)
Medtech (14629)
Mergers & acquisitions (19046)
Metabolic disorders (1388)
mRNA (183)
Multiple sclerosis (173)
NASH (23)
Neurodegenerative disease (365)
Neuropsychiatric disorders (104)
Neuroscience (3164)
Neurotech (1)
NextGen: Class of 2026 (6753)
Non-profit (4609)
Now hiring (65)
Obesity (659)
Opinion (312)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (243)
Parkinson's disease (307)
Partnered (35)
Patents (527)
Patient recruitment (540)
Peanut (63)
People (60123)
Pharmaceutical (58)
Pharmacy benefit managers (26)
Phase 1 (21871)
Phase 2 (30720)
Phase 3 (22973)
Pipeline (5860)
Policy (315)
Postmarket research (2607)
Preclinical (9306)
Press Release (65)
Prostate cancer (265)
Psychedelics (56)
Radiopharmaceuticals (309)
Rare diseases (960)
Real estate (5476)
Recruiting (66)
Regulatory (24932)
Reports (31)
Research institute (2570)
Resumes & cover letters (368)
Rett syndrome (30)
RNA editing (21)
RSV (77)
Schizophrenia (162)
Series A (263)
Series B (204)
Service/supplier (4)
Sickle cell disease (108)
Special edition (23)
Spinal muscular atrophy (169)
Sponsored (42)
Startups (3650)
State (2)
Stomach cancer (20)
Supply chain (106)
Tariffs (81)
The Weekly (88)
Vaccines (1055)
Venture capital (95)
Weight loss (445)
Women's health (93)
Worklife (20)
Date
Today (36)
Last 7 days (867)
Last 30 days (2772)
Last 365 days (30195)
2026 (4881)
2025 (30563)
2024 (35495)
2023 (39943)
2022 (51066)
2021 (55252)
2020 (53906)
2019 (46957)
2018 (35477)
2017 (32614)
2016 (31676)
2015 (37022)
2014 (29497)
2013 (24697)
2012 (26269)
2011 (26875)
2010 (24895)
Location
Africa (859)
Alabama (92)
Alaska (5)
Arizona (292)
Arkansas (14)
Asia (42053)
Australia (7855)
California (11311)
Canada (3338)
China (1180)
Colorado (481)
Connecticut (475)
Delaware (347)
Europe (94040)
Florida (1723)
Georgia (367)
Hawaii (3)
Idaho (64)
Illinois (906)
India (69)
Indiana (530)
Iowa (21)
Japan (448)
Kansas (128)
Kentucky (38)
Louisiana (28)
Maine (70)
Maryland (1454)
Massachusetts (8204)
Michigan (342)
Minnesota (659)
Mississippi (7)
Missouri (132)
Montana (33)
Nebraska (27)
Nevada (124)
New Hampshire (86)
New Jersey (3101)
New Mexico (28)
New York (2969)
North Carolina (1513)
North Dakota (9)
Northern California (5448)
Ohio (344)
Oklahoma (18)
Oregon (44)
Pennsylvania (2266)
Puerto Rico (24)
Rhode Island (50)
South America (1153)
South Carolina (68)
South Dakota (1)
Southern California (4484)
Tennessee (173)
Texas (1784)
United States (40576)
Utah (351)
Vermont (1)
Virginia (268)
Washington D.C. (82)
Washington State (934)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
697,402 Results for "precision therapeutics formerly known as skyline medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Press Releases
Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2026
·
5 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth
February 19, 2026
·
3 min read
Press Releases
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
February 4, 2026
·
4 min read
Opinion
Tomorrow’s Precision Therapeutics Depend on Precision Diagnostics
Only with the adoption of digital imaging and AI-powered analysis will next-generation precision oncology therapies reach their full potential and ensure no eligible patient is overlooked.
July 14, 2025
·
3 min read
·
Robert Monroe
Press Releases
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
February 24, 2026
·
6 min read
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
November 13, 2025
·
16 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
1 of 69,741
Next
